Terry Ridge, NP
Adult Health · Carmel, INNPI 1447345632
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,118 of the $19,734 with a category attached, or 61.4%. Novo Nordisk accounts for 97.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $12,308 and has fallen 99.2% since, to $92 in 2023. Among adult health clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $680.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$19K
- Abbott$162
- Lilly USA, LLC$111
- Johnson & Johnson$76
- Tandem Diabetes Care, Inc.$64
- Ascensia Diabetes Care US Inc.$28
- plus $18 from 1 others
What the payments were for
- Consulting fees$5,00325%
- Speaking & faculty fees$12,11861%
- Travel & lodging$1,5748%
- Food & beverage$9635%
- Education$760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $19,274 |
| Abbott | 3 | $162 |
| Lilly USA, LLC | 1 | $111 |
| Johnson & Johnson | 2 | $76 |
| Tandem Diabetes Care, Inc. | 1 | $64 |
| Ascensia Diabetes Care US Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$10,863
- Ozempic$1,495
- FreeStyle Libre$131
- MOUNJARO$111
How this compares
$19,734 in reported general payments places this provider in the 95th percentile of 391 adult health providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 273 | $244,968 |
| OzempicSemaglutide | 174 | $219,029 |
| TrulicityDulaglutide | 82 | $106,614 |
| Tresiba Flextouch U-200Insulin Degludec | 92 | $75,270 |
| MounjaroTirzepatide | 48 | $51,257 |
| RybelsusSemaglutide | 38 | $44,981 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 28 | $26,087 |
| Tresiba Flextouch U-100Insulin Degludec | 37 | $24,108 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 17 | $23,402 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 85 | $16,487 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $15,539 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 26 | $15,142 |
| Humalog Kwikpen U-100Insulin Lispro | 49 | $11,694 |
| FarxigaDapagliflozin Propanediol | 14 | $11,007 |
| Novolog FlexpenInsulin Aspart | 45 | $10,758 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $19,274 | $270,469230 claims |
| Boehringer IngelheimJardiance, Tradjenta | $18 | $253,427284 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $111 | $163,786146 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 391 adult health providers in Indiana.
Other adult health in Carmel
- Holly WilliamsCarmel$4K
- Megan SavkaCarmel$3K
- Jennifer BerryIndianapolis$50K
- Tajuana DavisZionsville$31K
- Patricia Damron-RobinsonMerrillville$20K
- Kristine StarcevichMerrillville$19K
- Jolyn Holliday VezaGreenfield$17K
- Anna MatulewiczMishawaka$14K
- Ludmila Pichugena-EmersonMiddlebury$14K
- Vincent SmithMerrillville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.